CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

CVS Health Corp. closed 34.84% short of its 52-week high of $80.75, which the company achieved on March 28th.

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

Pharmacies like Snyders rely on reimbursements to make ends meet. When his business dispenses prescriptions, the repayment ...

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...

This week's dividend activity included increased payouts from Lakeland Financial (LKFN) and Valero Energy (VLO) as well as ...

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...

CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

Piper Sandler named UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) as its top picks in the managed care space, arguing ...

Planet Fitness will be part of the Mercantile Center, a mixed-use property located downtown that includes 90 Front St., ...